Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report
| Autor: | Rahul R Tambe, Anupa Hinduja, Ami Varaiya, Suchithra Sunil, Amol Joshi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Voriconazole
medicine.medical_specialty Cutaneous mucormycosis Coronavirus disease 2019 (COVID-19) business.industry medicine.drug_class Secondary infection Antibiotics Mucormycosis Case Report Critical Care and Intensive Care Medicine Aspergillosis medicine.disease Dermatology Secondary invasive fungal infection Pneumonia medicine COVID-19 and mucormycosis business COVID-19-associated mucormycosis medicine.drug |
| Zdroj: | Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine |
| ISSN: | 1998-359X 0972-5229 |
| Popis: | Coronavirus disease-2019 (COVID-19)-associated mucormycosis is on the rise in the Indian subcontinent. We report a unique case of cutaneous mucormycosis in a case of newly diagnosed young diabetic patient with severe COVID-19 pneumonia with post-COVID lung fibrosis. Neither did he have any preceding trauma or wound, nor was there any evidence of any secondary dissemination. Cutaneous mucormycosis without evidence of either is unheard off. Possible risk factors in this case were multiple bacterial secondary infections with the use of higher antibiotics, use of voriconazole for possible aspergillosis, and steroid use. How to cite this article Tambe RR, Hinduja A, Sunil S, Varaiya A, Joshi A. Cutaneous Mucormycosis in a Patient of Severe COVID-19 Pneumonia: A Rarer than Rare Case Report. Indian J Crit Care Med 2021;25(11):1318–1319. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|